American Bio Medica Corporation reported break-eaven for the III. Quarter compare to earnings per share of $0.02 recorded in the same quarter a year ago an improvement compare to $0.00 realized in previous quarter.
III. Quarter
Earnings Per Share
Revenues
$ 0
$
0 Mill
$-0.02
Unch.-65.96 %
American Bio Medica's Revenue
fell by
-65.96 % in III. Quarter (Sep 30 2022) year on year,
to $0 million and
advanced by
12.97 % sequentially.
American Bio Medica is Expected to report next financial results on April 13, 2023.
American Bio Medica's
in III. Quarter recorded net loss of $-0.314 million, compare to net income of $0.663 million achieved in III. Quarter a year ago.
Sequentially
net loss narrowed from net loss of $-0.400 million realized in previous quarter.
Inventories declined by -9.31 % to $0.38 million from III. Quarter a year ago, sequentially inventories fell by -5.24 %.
ABMC's Cash flow
In III. Quarter company's net cash flow was $0 million
